Telehealth Addiction Treatment: What the Rules Allow

Quick answer

Telehealth can deliver counseling, outpatient care, and opioid treatment without an office visit. Federal rules currently let DEA-registered practitioners prescribe buprenorphine by phone or video, and broader controlled-substance flexibilities run through December 31, 2026. State medical boards add their own licensing requirements, so what you can get by telehealth depends on both layers.

If you have been putting off treatment because you cannot face a waiting room, the honest news is that a lot of treatment now happens through a screen or a phone. Telehealth can carry assessment, counseling, outpatient programs, and medication for opioid use disorder without an office visit. The limits are legal, not medical: federal telemedicine rules control controlled-substance prescribing, and each state's medical board adds its own rules on top.

This page explains the framework - what telehealth can deliver, what the federal rules currently allow, and where state rules change the picture. If you want the practical how-to of starting telehealth care yourself, our guide to telehealth addiction treatment covers the day-to-day side. And if things have gotten dangerous tonight, call 911. If you are in crisis and need to talk to someone, call or text 988.

What telehealth can deliver

At every level of care short of inpatient treatment, telehealth is a working option:

Assessment and level-of-care decisions can be made by video. A clinician can screen, diagnose (in states that permit remote diagnosis), and tell you whether you need detox, an outpatient track, or something more intensive.
Individual and group counseling runs well over video platforms; many intensive outpatient programs now mix in-person and virtual sessions.
Medication for opioid use disorder - buprenorphine and naltrexone - can be prescribed through telemedicine, subject to the federal and state rules below.
Psychiatric care for co-occurring conditions is routinely delivered remotely.

Detox and residential care are different. Those are physical, 24-hour settings, so telehealth cannot replace them in the moment - though telehealth counseling continues after them, and some inpatient admissions are coordinated from a remote first visit.

The Ryan Haight Act: the default rule

The nation's baseline rule is the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which generally requires at least one in-person medical evaluation before a practitioner can issue a prescription for a controlled substance that gets dispensed online. The act creates seven exceptions - categories of telemedicine practice that count in place of the in-person visit - and one of those categories lets the Drug Enforcement Administration and the Secretary of Health and Human Services jointly define additional safe circumstances by regulation. Everything below flows through that mechanism.

The buprenorphine telemedicine rule

In January 2025, DEA and HHS finalized the buprenorphine telemedicine rule (published at 90 FR 6504; the effective date was later moved to December 31, 2025). Under this rule, a DEA-registered practitioner who has never evaluated a patient in person can:

Prescribe a schedule III-V medication approved by the FDA for opioid use disorder - buprenorphine, for example - through an audio-video or audio-only encounter, after reviewing the prescription drug monitoring program data for the state where the patient is located and documenting that check.
Prescribe an initial quantity of up to a six-month total supply, split across multiple prescriptions as medically appropriate.
Continue beyond that window only by an in-person evaluation or another form of telemedicine that federal law specifically authorizes.

The pharmacist must verify the patient's identity before filling a prescription issued this way, and the patient can expect to present a government photo ID or an alternative document such as a utility bill, bank statement, or paycheck. The rule does not apply at all if the practitioner has already seen the patient in person - an established relationship simply continues under ordinary practice.

SAMHSA's question-and-answer guidance for practitioners clarifies the details, including what happens when a practitioner cannot access the PDMP (a seven-day supply is allowed after documenting the failed attempt) and that the six-month period is a one-time total, not a repeated window.

The broader temporary flexibilities

In parallel, DEA has repeatedly extended the COVID-era flexibilities that let practitioners prescribe the full schedule range without a prior in-person visit. The current extension - the fourth temporary one, published December 31, 2025 in the Federal Register at 90 FR 61301 - runs through December 31, 2026, permits schedule II-V prescribing over interactive audio-video systems, and allows schedule III-V opioid use disorder medications by audio-only encounter. DEA has said it may extend the rule again or replace it with a permanent framework.

That permanent framework is still in draft. DEA proposed a special registration for telemedicine on January 17, 2025 (90 FR 6541), which would create registration categories for practitioners and, for the first time, require online telemedicine platforms themselves to register with the agency. The comment period closed in March 2025 and the rule is not final, so nothing in it should be treated as current law. Until something replaces it, this page describes the rules as they stand - and we will update it if the regulatory posture changes.

What each state adds on top

Federal rules are a floor, not a ceiling. Every state assigns its own medical board the job of deciding things like whether an out-of-state clinician may treat you remotely, whether a prior in-person relationship is ever required, and whether audio-only visits count. The buprenorphine regulation itself notes that a practitioner must be authorized under both federal regulations and the laws of the state where they - and the patient - are located when the telemedicine encounter occurs.

Practically, that means three things to check before assuming a telemedicine appointment will work:

Licensure. The treating clinician is generally licensed in the state where you are physically located during the visit - not the state they work in.
Online-prescribing rules. States differ on controlled substances and audio-only care; the Center for Connected Health Policy's online-prescribing tracking is the closest thing to a national map.
Your own state law. Our state law pages for Florida, Kentucky, Missouri, Ohio, Pennsylvania, Tennessee, and West Virginia summarize each state's framework for substance use treatment, and the state medical board's telehealth policy page holds the current licensure rules.

What this means for the levels of care on this site

Outpatient and IOP - telehealth can carry the treatment itself, including virtual intensive outpatient sessions in many programs.
Medication-assisted treatment - buprenorphine induction and maintenance can start from a video or phone encounter under the buprenorphine rule; methadone requires an opioid treatment program.
Residential and PHP - these are in-person settings, but telehealth often supports pre-admission assessment and follow-up care.
Aftercare and counseling - ongoing recovery support is one of telehealth's strongest fits, because it removes the distance barrier that tends to drag people out of care.

If you would rather talk it through than read, call or text (800) 653-9376 any time.

Sources

Sources cited on this page:

Questions about Telehealth Addiction Treatment

Can a doctor diagnose me and treat my substance use disorder over a video call?

Yes. Assessment, counseling, and outpatient treatment are routine telehealth services. The harder question is prescribing controlled substances, which is governed by federal telemedicine rules and your state's licensing rules rather than by telehealth in general.

Can buprenorphine (Suboxone) be prescribed over the phone without an in-person visit?

Yes, under the DEA and HHS buprenorphine telemedicine rule. A practitioner who has never seen you in person can initiate buprenorphine by audio-only or audio-video visit, check your state's prescription drug monitoring program data first, and prescribe an initial supply that counts toward a six-month total.

What happens after the six-month buprenorphine period?

The rule allows one six-month supply period per patient via telemedicine when there has never been an in-person evaluation. After that, the practitioner must either see you in person or continue care through forms of telemedicine specifically authorized under federal law.

Do the federal rules work the same in every state?

No. Federal rules set a floor, not a ceiling. A practitioner generally must be licensed in the state where the patient is located during the visit, and states add their own telehealth requirement - some limit audio-only care, some require a prior in-person relationship for certain prescribing. Your state medical board's telehealth policy is the place to check.

Does insurance cover telehealth addiction treatment?

Most commercial, Medicaid, and Medicare plans cover telehealth services, but coverage details - which platforms, audio-only or video-only, cost-sharing - vary by plan. Ask your plan's member services line or your plan documents; your ID card lists that number.